Eisai
4523.T
#2105
Rank
A$11.04 B
Marketcap
$39.16
Share price
-4.47%
Change (1 day)
-34.37%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.26

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.47. In 2022 the company made an earnings per share (EPS) of $2.55 a decrease over its 2021 EPS that were of $11.31.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.2627.94%
2022$2.55-77.48%
2021$11.31-41.88%
2020$19.46-0.94%
2019$19.6452.59%
2018$12.87124.17%
2017$5.74-49.42%
2016$11.3537.08%
2015$8.28-11.75%
2014$9.39-3.23%
2013$9.70-18.56%
2012$11.91-15.51%
2011$14.10-3.75%
2010$14.65-1.36%
2009$14.85